Wonkwang Bone Regeneration Research Institute, Wonkwang University, Iksan, Jeonbuk 570-749, Republic of Korea; Bonecell Biotech Inc., 77 Dunsan-dong, Seo-gu, Daejeon 302-830, Republic of Korea.
Bonecell Biotech Inc., 77 Dunsan-dong, Seo-gu, Daejeon 302-830, Republic of Korea.
J Biosci Bioeng. 2014 Oct;118(4):469-75. doi: 10.1016/j.jbiosc.2014.03.014. Epub 2014 Apr 24.
Fibrin polymers are widely used in the tissue engineering field as biomaterials. Although numerous researchers have studied the fabrication of scaffolds using fibrin glue (FG) and bone powder, the effects of varied fibrinogen content during the fabrication of scaffolds on human mesenchymal stem cells (hMSCs) and bone regeneration remain poorly understood. In this study, we formulated scaffolds using demineralized bone powder and various fibrinogen concentrations and analyzed the microstructure and mechanical properties. Cell proliferation, cell viability, and osteoblast differentiation assays were performed. The ability of the scaffold to enhance bone regeneration was evaluated using a rabbit calvarial defect model. Micro-computed tomography (micro-CT) showed that bone powders were uniformly distributed on the scaffolds, and scanning electron microscopy (SEM) showed that the fibrin networks and flattened fibrin layers connected adjacent bone powder particles. When an 80 mg/mL fibrinogen solution was used to formulate scaffolds, the porosity decreased 41.6 ± 3.6%, while the compressive strength increased 1.16 ± 0.02 Mpa, when compared with the values for the 10 mg/mL fibrinogen solution. Proliferation assays and SEM showed that the scaffolds prepared using higher fibrinogen concentrations supported and enhanced cell adhesion and proliferation. In addition, mRNA expression of alkaline phosphatase and osteocalcin in cells grown on the scaffolds increased with increasing fibrinogen concentration. Micro-CT and histological analysis revealed that newly formed bone was stimulated in the scaffold implantation group. Our results demonstrate that optimization of the fibrinogen content of fibrin glue/bone powder scaffolds will be beneficial for bone tissue engineering.
纤维蛋白聚合物作为生物材料广泛应用于组织工程领域。尽管许多研究人员已经研究了使用纤维蛋白胶 (FG) 和骨粉制造支架,但在制造支架时纤维蛋白原含量的变化对人骨髓间充质干细胞 (hMSC) 和骨再生的影响仍知之甚少。在这项研究中,我们使用脱钙骨粉和不同浓度的纤维蛋白原来配方支架,并分析了微观结构和机械性能。进行了细胞增殖、细胞活力和成骨细胞分化测定。使用兔颅骨缺损模型评估了支架增强骨再生的能力。微计算机断层扫描 (micro-CT) 显示骨粉均匀分布在支架上,扫描电子显微镜 (SEM) 显示纤维蛋白网络和平坦的纤维层连接相邻的骨粉颗粒。当使用 80mg/mL 纤维蛋白原溶液配方支架时,与 10mg/mL 纤维蛋白原溶液相比,孔隙率降低了 41.6±3.6%,而压缩强度增加了 1.16±0.02Mpa。增殖实验和 SEM 表明,使用较高纤维蛋白原浓度制备的支架支持和增强了细胞黏附和增殖。此外,在支架上生长的细胞中碱性磷酸酶和骨钙素的 mRNA 表达随着纤维蛋白原浓度的增加而增加。micro-CT 和组织学分析显示支架植入组刺激了新形成的骨。我们的结果表明,优化纤维蛋白胶/骨粉支架中的纤维蛋白原含量将有益于骨组织工程。